ESSILOR TO ACQUIRE JOHNSON & JOHNSON
VISION CARE INC.’S OPHTHALMIC LENS BUSINESS
Essilor to Acquire The Spectacle Lens Group

DALLAS -- (June 8, 2005) – Essilor and US-based Johnson & Johnson have signed an agreement whereby Essilor will acquire The Spectacle Lens Group, Johnson & Johnson Vision Care Inc.’s ophthalmic lens business. Created in 1999, The Spectacle Lens Group developed the Definity™ brand of progressive lenses, featuring unique Dual Add™ technology that divides progressive add power between the front and back surfaces.

Definity™ was introduced in select US test markets in late 2002 and is well respected among local eye care professionals and consumers. To help speed further development, Essilor will continue to manufacture Definity™ progressive lenses and distribute them in the United States through its traditional marketing and distribution networks.

“This acquisition is fully in line with Essilor’s dedication to providing quality products to Eyecare Professionals and consumers. Through offering Definity, Eyecare Professionals will be able to provide their customers with more options,” said Hubert Sagnières, president of Essilor of America. “We are also excited for our employees and customers as our two companies share a similar focus on technological advancement and this common ground is extremely important as we prepare for future growth and success.”

The acquisition is fully in line with Essilor’s strategy of offering innovative, high value-added products. The Dual Add™ and related technologies will enhance the Company’s research programs to improve and personalize its offering of progressive lenses.

The terms for the agreement were not disclosed. The agreement is subject to approval by US antitrust authorities.